---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-027409"
form_type: "8-K"
ticker: "NGNE"
cik: "0001404644"
company_name: "Neurogene Inc."
filed_at: "2022-10-31T23:59:59+00:00"
generated_at: "2026-06-22T21:30:32.460461+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Neoleukin receives Nasdaq delisting notice for bid price below $1.00

## Summary
- Nasdaq notice on Oct 26, 2022 for non-compliance with minimum bid price rule (5550(a)(2)).
- Initial 180-day cure period ends April 24, 2023; needs $1.00+ close for 10 consecutive days.
- May seek transfer to Nasdaq Capital Market for second 180-day grace period if eligible.
- Company evaluating actions but no decisions made; delisting risk remains if not cured.

## SEC filing metadata
- accession: 0001628280-22-027409
- form_type: 8-K
- ticker: NGNE
- cik: 0001404644
- company_name: Neurogene Inc.
- filed_at: 2022-10-31T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404644/000162828022027409/0001628280-22-027409-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404644/000162828022027409/nltx-20221026.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-027409
- JSON: https://secwatch.observer/filing/0001628280-22-027409.json
- Plain text: https://secwatch.observer/filing/0001628280-22-027409.txt

## Key facts
- Listing & Compliance Notices
  Neurogene Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: October 26, 2022, Neoleukin Therapeutics, Inc. (the “Company”) received notice (the "Notice") from the Listing Qualifications staff of the Nasdaq Stock Market LLC (“Nasdaq”) that, because the closing bid price for the Company's common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5550(a)(2). The Notice has no immediate effect on the listing of the Company's common stock on the Nasdaq Global Market. Pursuant to Nasdaq Listin
  evidence_url: https://www.sec.gov/Archives/edgar/data/1404644/000162828022027409/0001628280-22-027409-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.